OTC · PKPH
Peak Pharmaceuticals, Inc.
Financial Services · Shell Companies
$1.55
Up+$0.00 (+0.00%)
Updated Aug 27, 2026, 12:37 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 607.32K
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- — – —
- Volume
- 1
- Avg. volume
- 504
Price performance
PKPH price history
1M range · 0 trading sessions · Daily adjusted prices
PKPH does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest PKPH news
The latest Smart Investors Daily articles mentioning PKPH.
Stock researchCompany · Overview
PKPH research
Overview
Company profile and research snapshot.
Company profile
Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
